RDY
$71.14
Revenue | $72148Mn |
Net Profits | $13789Mn |
Net Profit Margins | 19.11% |
Dr. Reddy's Laboratories Ltd.’s revenue jumped 6.57% since last year same period to $72148Mn in the Q4 2023. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated 4.86% jump in its revenue since last 3-months.
Dr. Reddy's Laboratories Ltd.’s net profit jumped 10.57% since last year same period to $13789Mn in the Q4 2023. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -6.83% fall in its net profits since last 3-months.
Dr. Reddy's Laboratories Ltd.’s net profit margin jumped 3.75% since last year same period to 19.11% in the Q4 2023. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -11.15% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.82 |
EPS Estimate Current Year | 0.82 |
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current quarter stand at 0.82 - a -98.83% fall from last quarter’s estimates.
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current year stand at 0.82.
Earning Per Share (EPS) | 0 |
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2024. This indicates that the Dr. Reddy's Laboratories Ltd. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-22 | 0.82 | 0 | -100% |